Stephens Consulting, LLC Aim Immuno Tech Inc. Transaction History

Stephens Consulting, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Jan 19, 2023	SELL	$0.67 - $1.18 $1,005 - $1,770	-1,500 Reduced 50.0%	1,500 $1.59 Million
Q4 2021 Jan 19, 2023	BUY	$0.92 - $1.96 $2,760 - $5,880	3,000 New	3,000 $2.76 Million

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Stephens Consulting, LLC with notifications on news.